Arizona Form 308-S
Credit for Increased Research Activities
The "Two-Line" Definition: Form 308-S is the mandatory filing for Arizona S Corporations to calculate the Research & Development (R&D) tax credit generated by Qualified Research Expenses (QREs) and pass that credit through to shareholders.
This interactive report dissects the mechanics of Form 308-S. Unlike federal C-Corps, Arizona S-Corporations do not claim the credit directly against income tax; instead, they function as a conduit. The credit is calculated at the entity level based on the excess of current research expenses over a base amount, and then distributed to shareholders via Schedule K-1(NR).
Identifying Qualified Research Expenses (QREs)
Form 308-S relies heavily on Federal Section 41 definitions. Before calculating the credit, an S-Corp must aggregate its QREs. This section breaks down the three primary "buckets" of expenses that drive the credit value. Interact with the cards below to understand the nuance of each category.
1. W-2 Wages
Wages paid to employees strictly for "Qualified Services." This includes direct research, direct supervision, and direct support of research.
2. Supplies
Tangible property used in the research process. This includes prototypes, testing materials, and chemicals.
3. Contract Research
Amounts paid to third parties (US-based) to perform research on your behalf.
Arizona R&D Credit Estimator
Form 308-S calculates the credit based on the "Excess" of current year QREs over a calculated "Base Amount." Use this tool to simulate how increasing expenses impacts the credit available for distribution.
Note: This simulation assumes the standard method for simplicity. Actual filing requires complex historical gross receipts analysis.
Step 1: Input Financials
Calculated at 65% automatically.
Historically derived average. Must be at least 50% of current QREs.
Step 2: Visualize the Spread
The Pass-Through Mechanism
Crucially, the S-Corporation itself usually pays no income tax. Therefore, Form 308-S is an information return. The credit travels from the entity to the owners. This flow diagram illustrates the lifecycle of the credit data.
Filing Lifecycle & Deadlines
Tax Year End (Dec 31)
Aggregate all W-2s, invoices, and supply logs. Ensure documentation proves the "Qualified" nature of research.
March 15 (Or Extension)
S-Corp files Arizona Form 120S. Form 308-S is attached to this return. K-1s are issued to shareholders.
April 15
Shareholders file Personal Form 140, attaching Form 308 to claim their share of the credit passed from the S-Corp.
Guidance & Limitations
- × Non-Refundable: For shareholders, the credit can zero out tax liability but cannot generate a refund check (unless electing 308-I small business rules).
- ✓ Carryover: Unused credits can be carried forward for 15 consecutive taxable years.
- ! Documentation: ADOR requires project-level accounting. Estimates are heavily scrutinized during audits.
Arizona Form 308-S: Navigating the Pass-Through of the Arizona R&D Tax Credit
Arizona Form 308-S, officially titled “Credit for Increased Research Activities – Distribution to Shareholders of an S Corporation,” is the mandatory state tax document used by S corporations to formally allocate the Arizona Research and Development (R&D) tax credit benefit to their eligible shareholders. It serves as the official compliance bridge, transferring the tax credit calculated at the entity level to the individual shareholders who claim the credit on their personal state income tax returns.
This distribution mechanism is critical because S corporations are pass-through entities, meaning the economic benefits and liabilities generated by the business flow directly to the owners. For the high-value Arizona R&D tax credit, which comprises both non-refundable and potentially refundable components, Form 308-S ensures accurate, proportionate distribution based on ownership percentage, integrating the requirements of both the Arizona Department of Revenue (ADOR) and the Arizona Commerce Authority (ACA).
Statutory and Regulatory Foundation of the Arizona R&D Credit
The foundation of the Arizona R&D incentive is rooted in state statute, aimed at encouraging incremental research and development activities conducted exclusively within the state.1 This incentive is designed to bolster key Arizona industries, including technology, aerospace, biotechnology, and manufacturing.2
Legal Framework and Administrative Oversight
The non-refundable portion of the credit is governed by Arizona Revised Statutes (A.R.S.) § 43-1168 (for corporate taxpayers) and A.R.S. § 43-1074.01 (for individuals) and is historically administered by ADOR.1
The high-demand refundable portion of the R&D tax credit is established by A.R.S. § 41-1507 and is administered by the Arizona Commerce Authority (ACA).1 This dual administration—with the ACA certifying eligibility and the refund amount, and ADOR handling the tax filing and payment—necessitates precise coordination, which is partially facilitated by Form 308-S.
Calculation Methodology and Tiered Rates
Arizona mandates that the computation of the credit amount adheres closely to the definitions of qualified research expenses (QREs) and basic research payments found in Internal Revenue Code (IRC) Section 41.3 However, a key distinction is that only expenses sourced and incurred within the State of Arizona qualify for the state credit.3
Mandatory Calculation Method
The state law dictates the use of the federal regular (incremental) credit computation method, measuring QREs that exceed a predetermined base amount.2 Taxpayers are explicitly prohibited from using the federal Alternative Simplified Credit (ASC) method.3 This regulatory restriction requires businesses to comply with the more involved regular credit calculation, which necessitates determining a fixed-base percentage and averaging prior years’ Arizona gross receipts.2 This preference for the regular method likely reflects the state’s requirement for a robust and consistent framework to ensure that only documented, incremental R&D investment is rewarded, increasing the complexity of the initial Form 308 preparation for the S corporation.
Credit Rate Structure
The credit uses a tiered rate structure for calculating the benefit of excess qualified research expenses (QREs) over the base amount:
- Tier 1 (Up to $2.5 Million Excess): The credit is equal to 24% of the first $2.5 million in qualifying expenses (valid through tax year 2030).1
- Tier 2 (Over $2.5 Million Excess): The credit is equal to $600,000 plus 15% of the qualifying expenses in excess of $2.5 million (valid through tax year 2030).5
After 2030, the rates are scheduled to decrease to 20% and 11%, respectively.5
Additional University R&D Credit
Arizona offers an additional, nonrefundable income tax credit for taxpayers who make basic research payments to an Arizona Board of Regents university (Arizona State University, Northern Arizona University, or the University of Arizona).7 This additional credit is equal to 10% of the basic research payments that constitute excess expenses over the base amount.1 To claim this credit, the taxpayer must receive a letter of certification from the ACA and a letter of approval certifying the credit amount from ADOR, highlighting the dual agency involvement for specialized incentives.8
Form 308-S: The S Corporation Flow-Through Compliance
S corporations that generate the R&D credit must use Form 308-S to formalize the distribution to their individual shareholders.10 This form is mandatory when the S corporation has claimed the Credit for Increased Research Activities and elected to pass it through, establishing a clear link in the compliance triad: Form 308 (S Corp Calculation) $\rightarrow$ Form 308-S (Shareholder Allocation) $\rightarrow$ Form 308-I (Shareholder Claim).3
Mandate and Filing Requirements
The S corporation must complete a separate Form 308-S for each shareholder.12 Upon completion, the S corporation must include a copy of all completed Form 308-S documents with its own Arizona corporate return (Form 120S) and must provide a copy to each shareholder.11 An S corporation is allowed to claim this credit against income taxed at the corporate level, or it may make an irrevocable election to pass the credit through to its shareholders.3
Identifying Eligible Shareholders
Form 308-S requires the S corporation to list the shareholder’s name, Social Security Number (SSN), and their precise proportionate share percentage of the credit.3
The Grantor Trust Clarification
A specific instruction governs the handling of trusts. Generally, Form 308-S should not be completed for trust or estate shareholders.12 However, a notable exception exists for S corporation shares owned by a grantor trust that is disregarded for federal income tax purposes. In this instance, the ownership is treated as belonging to the individual grantor, and the credit must be allocated to and claimed by the grantor.12
This regulation requires the S corporation’s tax compliance team to move beyond standard federal K-1 reporting conventions and ensure accurate identification of the true taxpayer for Arizona purposes. If the S corporation defaults to listing the trust’s Employer Identification Number (EIN) as the recipient instead of the individual grantor’s SSN, the shareholder could face immediate challenges claiming the credit on their personal return (Form 308-I), as ADOR’s system relies on SSN/EIN matching for verification. Therefore, detailed internal documentation confirming the federal tax status of all trust shareholders is essential for accurate Form 308-S preparation.12
ADOR Guidance: Allocating the Non-Refundable Credit (Part 2 Analysis)
Part 2 of Form 308-S is dedicated to distributing the general, non-refundable portion of the R&D credit.
Required Inputs and Distribution Mechanics
The distribution process follows a strict mathematical allocation:
- Line 3: S Corporation Total Credit: The S corporation enters the total R&D credit amount calculated at the entity level, which is sourced from Form 308, Part 4, Line 29.12
- Line 4: Shareholder’s Non-Refundable Portion: The amount on Line 3 is multiplied by the shareholder’s proportionate share percentage listed in Line 2(c). This result represents the shareholder’s portion of the non-refundable R&D credit.12
- Shareholder Claim Destination: Shareholders use the amount from Form 308-S, Line 4, and carry it forward to their individual return, specifically Form 308-I, Part 3, Line 25.12
Management of Unused Non-Refundable Credits
While the R&D credit is generally non-refundable, any amount exceeding the shareholder’s current year income tax liability is not forfeited. Arizona provides generous carryforward provisions for unused amounts. Credits generated for taxable years beginning before January 1, 2022, may be carried forward for fifteen (15) consecutive taxable years.3 Credits generated in subsequent years (post-2021) are eligible for a ten (10) year carryforward period.2
ACA Guidance: Allocating the Refundable Portion (Part 3 Analysis)
The Arizona refundable R&D tax credit program is a competitive, high-value incentive available to qualified small businesses. Part 3 of Form 308-S handles the allocation of this specific, often capped, refundable amount. The process is administered by the ACA, imposing stringent prerequisites on the S corporation before any amount can be passed through.
Refundability Prerequisites for the S Corporation
To qualify for the refund path, the S corporation must meet several criteria and procedural requirements:
- Employee Threshold: The S corporation must employ fewer than 150 full-time employees worldwide as of the last day of the taxable year for which the expenses are claimed.4
- ACA Certification Requirement: The S corporation must electronically submit an Application for a refund to the ACA and receive a Certificate of Qualification prior to claiming the credit.4
- Compliance Documentation: The application requires significant data, including the number of worldwide full-time employees, gross payroll, capital investment in Arizona, and an affidavit agreeing to furnish expenditure records and permit site visits.4 Furthermore, the S corporation must confirm compliance with the state’s employer requirement for enrollment in E-Verify.4
- Information Sharing: The S corporation must execute ADOR’s Form 285B, authorizing the ACA to obtain confidential taxpayer information from ADOR for application review and certification purposes.4
Strategic Timing and Annual Cap Competition
Refunds are subject to a strict annual statewide cap. The ACA is authorized to approve Applications up to a total of $5 million per calendar year.2 Although legislative efforts (such as Senate Bill 1254) have aimed to increase this cap to $10 million 13, the current operational limit remains $5 million. The cap is often fully allocated early in the year, as seen with the exhaustion of the 2025 cap.14
Filing Precedence Risk
Applications are processed on a first-come, first-served basis, with a random selection process prioritizing all substantially complete applications received on the first business day of the calendar year.4 Crucially, a taxpayer is ineligible for the refundable credit if they file their tax return with ADOR before submitting their application and receiving the Certificate of Qualification from the ACA.4
This rule creates a critical strategic timing issue, especially for fiscal year taxpayers. A fiscal year filer may apply immediately following the close of their fiscal year, provided the $5 million cap has not yet been exhausted. If the cap is reached mid-year, the fiscal year taxpayer must delay filing their return until the cap reopens on the first business day of the next calendar year.14
Distribution Mechanics for the Refundable Portion
Part 3 procedures commence only if the S corporation confirms receipt of the ACA Certificate of Qualification.12
- Line 5: S Corporation Maximum Refundable Amount: The S corporation enters the total maximum refund amount authorized by the ACA, which is reported on Form 308, Part 5, Line 35.12
- Line 6: Shareholder’s Maximum Refundable Portion: This amount is calculated by multiplying the amount on Line 5 by the shareholder’s proportionate share percentage shown in Line 2(c).12
- Shareholder Claim Destination: Shareholders use the amount from Form 308-S, Line 6, on their individual return, specifically Form 308-I, Part 5, Line 31c, and must attach a copy of the ACA Certificate of Qualification.4
Financial and Tax Implications of the Refund Election
The refundable program imposes financial limitations and requires a mandatory tradeoff.
- Per-Taxpayer Cap: The maximum refund amount is capped at $100,000 per taxpayer (shareholder) per tax year, regardless of the size of the total credit calculated.2
- Forfeiture of Carryforward: If the S corporation and its shareholders elect to pursue the refund, the refund is limited to 75% of the excess credit (current R&D credit minus current tax liability). The remaining portion of the unused credit—the other 25% and any amount exceeding the $100,000 shareholder cap—is irrevocably waived.4
- Processing Fee: A nonrefundable processing fee equal to 1% of the total tax credit being refunded must be remitted to the ACA.4
This forfeiture provision presents a critical tax planning decision. The immediate liquidity provided by the refund (limited to 75% and capped at $100,000) must be weighed against the value of the non-refundable credit, which can be carried forward for up to 10 years.2 For S corporations anticipating substantial future taxable income, the long-term benefit of maximizing the carryforward value may significantly outweigh the capped, immediate cash refund. Tax teams must perform rigorous net present value analysis to determine the optimal strategy before the irrevocable ACA application is submitted.
Comprehensive Case Study: Allocating the R&D Credit to Shareholders
The following example illustrates the calculation and allocation process required for an S corporation utilizing Form 308-S for a tax year prior to 2030.
Scenario Definition: Advanced Research Corp (ARC), TY 2024
| Parameter | Value | Notes |
| Entity Type | S Corporation (ARC) | Fewer than 150 employees, eligible for refund path. |
| Total Arizona QREs (2024) | $3,500,000 | QREs incurred within Arizona. |
| Calculated Base Amount | $1,500,000 | Using the mandatory Regular Method calculation. |
| Shareholder B Ownership | 20% | Shareholder is an individual eligible to claim the credit. |
S Corporation Total Credit Calculation (Internal Form 308 Data)
- Excess QREs: $3,500,000 (QREs) – $1,500,000 (Base) = $2,000,000
- Credit Calculation (Tier 1): The excess QREs of $2,000,000 fall entirely within the 24% Tier 1 rate (since they are less than $2.5 million).5
- Total General R&D Credit (Form 308, Line 29): $\$2,000,000 \times 24\% = \$480,000$
- Maximum Refund Calculation (ACA Certified): Assuming ARC applies and receives ACA certification, the maximum refundable pool must be determined. While the excess credit is $480,000, the proportionate share allocated to any single shareholder cannot result in a refund exceeding $100,000.4 Therefore, the total maximum refundable credit that ARC can pass through to all shareholders is limited by the proportional distribution necessary to prevent any single shareholder from receiving a refund exceeding this cap. For simplicity in this case study, we assume the total refundable pool certified by ACA and entered on Form 308, Line 35 is $100,000.
Line-by-Line Example Completion for Shareholder B (Form 308-S)
This demonstrates the allocation required for Shareholder B (20% ownership).
Example Pass-Through Calculation via Form 308-S (Shareholder B, 20%)
| Form 308-S Line | Description | Source/Calculation | Amount |
| 2(c) | Shareholder Proportionate Share | Defined Ownership Percentage | 20% |
| 3 | Total R&D Credit (Non-Refundable Base) | Form 308, Line 29 | $480,000 |
| 4 | Shareholder B’s Non-Refundable Credit | $\$480,000 \times 20\%$ | $96,000 |
| 5 | Maximum Refundable Amount (ACA Approved) | Form 308, Line 35 | $100,000 |
| 6 | Shareholder B’s Maximum Refundable Credit | $\$100,000 \times 20\%$ | $20,000 |
Shareholder B would receive a copy of this Form 308-S, attach it to their personal tax return (along with the ACA Certificate of Qualification), and claim $96,000 on Form 308-I, Part 3, Line 25, and $20,000 on Form 308-I, Part 5, Line 31c.12
Compliance Checklist and Audit Readiness
Effective compliance with the Arizona R&D credit involves stringent record-keeping and careful synchronization of state and federal filing dates.
Documentation Requirements
S corporations must maintain detailed documentation to support the credit calculation, which includes records proving all QREs were incurred within Arizona, all data used for the base amount calculation (if using the regular method), and clear evidence of the total number of worldwide employees to meet the 150-employee threshold for refundability.4
For refundable claims, the S corporation must:
- Ensure copies of the executed Form 308-S are provided to each shareholder.12
- Include a copy of the ACA Certificate of Qualification with the S corporation’s tax return.4
- Require shareholders to attach both Form 308-S and the ACA Certificate to their individual returns (Form 308-I).8
Fiscal Year Synchronization Requirements
A critical complexity arises when an S corporation files on a fiscal year basis while its shareholders file on a calendar year basis. ADOR guidance stipulates that the calendar-year shareholder must claim the credit on their tax return for the year in which the S corporation’s fiscal year ends.12
This rule requires S corporation compliance teams to closely monitor the ACA’s calendar year cap allocation schedule, as highlighted in Section V. If a fiscal year S corporation generates a credit mid-year, the ACA application must be submitted immediately upon the close of the fiscal year to secure a portion of the competitive cap before it is exhausted. If the S corporation files its return with ADOR prematurely, the shareholders permanently forfeit the opportunity for a refund.4
Conclusion
Arizona Form 308-S is more than a required tax form; it is the official mechanism that operationalizes the Arizona R&D tax credit for S corporation shareholders. Its accurate completion is essential for transferring the calculated benefit from the entity level (Form 308) to the individual level (Form 308-I).
Successful utilization of the Arizona R&D tax credit, especially the valuable refundable portion, requires sophisticated tax management that extends beyond mere calculation. Compliance teams must meticulously verify the Arizona sourcing of QREs, ensure the calculation adheres to the mandated regular credit method (prohibiting the ASC), and, critically, manage the competitive timing imposed by the ACA’s annual cap. When evaluating the refundable path, S corporations must strategically weigh the immediate cash benefit, which is subject to a 75% limit and a $100,000 per-taxpayer cap, against the long-term value of the non-refundable credit’s 10-year carryforward period. Form 308-S is the final, pivotal document that ratifies this complex, multi-layered strategic decision for Arizona’s innovative businesses.
Are you eligible?
Why choose us?
Pass an Audit?
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
Never miss a deadline again
Stay up to date on IRS processes
Discover R&D in your industry
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state
